清爽的以菱
Lv1
50 积分
2024-08-08 加入
-
Clinical development times for innovative drugs
1天前
待确认
-
What matters most in commercial success: first-in-class or best-in-class?
1天前
已完结
-
Chinese innovative drug R&D trends in 2024
4天前
已完结
-
Different Development Strategies Affecting Japan’s Drug lag between Japan-Based and Foreign-Based Companies
22天前
已完结
-
Investigating the origins of recent pharmaceutical innovation
1个月前
已完结
-
Biopharma M&A flow picks up
1个月前
已完结
-
Safety, pharmacokinetics and pharmacodynamics of HRS‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial
1个月前
已完结
-
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
1个月前
已完结